PMA P100024S001

Device
HER2 CISH PHARMADX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S001
Product code
NYQ
Decision date
2012-02-01
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Approval order statement
APPROVAL FOR AN UPDATE OF THE SOFTWARE DOCUMENTATION FOR DAKOLINK SOFTWARE VERSION 3.0 TO DAKOLINK VERSION 3.1.1.

Current openFDA PMA Record#

Device
HER2 CISH PHARMADX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S001
Product code
NYQ
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Decision date
2012-02-01
Decision code
APPR
Date received
2011-12-07
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
APPROVAL FOR AN UPDATE OF THE SOFTWARE DOCUMENTATION FOR DAKOLINK SOFTWARE VERSION 3.0 TO DAKOLINK VERSION 3.1.1.